Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “First-line Chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00791154
What this trial is testing

QUILT-2.013: First-Line Treatment for Extensive Stage Small Cell Lung Cancer

Who this might be right for
Lung CancerSmall Cell Lung CancerSolid Tumors+1 more
NantCell, Inc. 213
Testing effectiveness (Phase 2)Study completedNCT07824505
What this trial is testing

Lucitanib (AL3810) in Patients With Advanced Thymic Carcinoma After Chemotherapy

Who this might be right for
Advanced Thymic Carcinoma
Haihe Biopharma Co., Ltd. 74
Early research (Phase 1)Looking for participantsNCT07481383
What this trial is testing

A First-in-Human Study to Evaluate Implantable Iontophoresis Chemotherapy Delivery Device With Gemcitabine Once Weekly or Twice Weekly in Participants With Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma Non-resectable
Continuity Biosciences, LLC 12
Not applicableStudy completedNCT01915056
What this trial is testing

A Geriatric Assessment Intervention for Older Cancer Patients Receiving Chemotherapy

Who this might be right for
Cancer
University of Rochester 80
Testing effectiveness (Phase 2)UnknownNCT04308837
What this trial is testing

A Phase II Trial of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) With Chemoradiation

Who this might be right for
Gastric CancerStomach Cancer
Icahn School of Medicine at Mount Sinai 29
Not applicableUnknownNCT00400907
What this trial is testing

Observation in Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma Treated on Clinical Trial CAN-NCIC-LY9

Who this might be right for
Long-term Effects Secondary to Cancer Therapy in AdultsLymphoma
German High-Grade Non-Hodgkin's Lymphoma Study Group 667
Testing effectiveness (Phase 2)Ended earlyNCT02846792
What this trial is testing

Nivolumab and Plinabulin in Treating Patients With Stage IIIB-IV, Recurrent, or Metastatic Non-small Cell Lung Cancer

Who this might be right for
ALK Gene TranslocationEGFR Activating MutationRecurrent Non-Small Cell Lung Carcinoma+3 more
University of Washington 5
Testing effectiveness (Phase 2)UnknownNCT04733963
What this trial is testing

Fruquintinib Plus Capecitabine Versus Bevacizumab Plus Capecitabine as Maintenance Therapy Following First-line Treatment for Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine 112
Testing effectiveness (Phase 2)UnknownNCT06172634
What this trial is testing

A Single-center Clinical Study to Evaluate the Safety and Efficacy of Autologous Bone Marrow-derived DCs(CellgramDC-WT1) and Immune Checkpoint Inhibitors in Patients With Metastatic Pancreatic Cancer Who Have Failed First-line or More Standard Chemotherapy

Who this might be right for
Pancreas Cancer
Soonchunhyang University Hospital 10
Large-scale testing (Phase 3)Study completedNCT00355199
What this trial is testing

Comparison of HD Chemotherapy Followed by Auto-transplant and R-CHOP in High Risk Patients With DLBCL.

Who this might be right for
Diffuse Large B-Cell Lymphoma
Gruppo Italiano Terapie Innovative nei Linfomi 246
Not applicableStudy completedNCT01740804
What this trial is testing

Dynamic Circulating Tumor Cell (CTC) Changes During the Chemotherapy in NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell LungCell, Circulating Tumor
Guangdong Association of Clinical Trials 180
Testing effectiveness (Phase 2)UnknownNCT01747707
What this trial is testing

Cisplatin,Docetaxel and S-1 for Advanced Gastric and Gastroesophageal Junction Cancer

Who this might be right for
Gastric CancerGastroesophageal Junction Cancer
Chinese Academy of Medical Sciences 40
Testing effectiveness (Phase 2)Study completedNCT02271464
What this trial is testing

Maintenance Bevacizumab Only or Bevacizumab Plus Metronomic Chemotherapy in Advanced Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Azienda Ospedaliero, Universitaria Pisana 232
Large-scale testing (Phase 3)Not Yet RecruitingNCT07802821
What this trial is testing

A Study Comparing QLC5508 in Combination With QL2107 Versus Tislelizumab Plus Platinum-based Chemotherapy in Participants Wih Treatment-naïve Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Extensive-stage Small Cell Lung Cancer
Qilu Pharmaceutical Co., Ltd. 556
Large-scale testing (Phase 3)Study completedNCT00561119
What this trial is testing

Maintenance Versus Observation After 6 Cycles of Gemcitabine Plus Paclitaxel in Pts With Advanced Breast Cancer

Who this might be right for
Advanced Breast Cancer
Samsung Medical Center 326
Testing effectiveness (Phase 2)Looking for participantsNCT06670911
What this trial is testing

Low-dose Pembrolizumab Plus Chemotherapy for the First-Line Treatment of Persistent, Recurrent, or Metastatic Cervical Cancer.

Who this might be right for
Persistent, Recurrent, or Metastatic Cervical Cancer
Instituto Nacional de Cancer, Brazil 44
Large-scale testing (Phase 3)Ended earlyNCT01200212
What this trial is testing

Study to Determine the Efficacy of a Taxane and Bevacizumab With or Without Capecitabine as First Line Chemotherapy in Patients With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
GBG Forschungs GmbH 432
Large-scale testing (Phase 3)Not Yet RecruitingNCT07328919
What this trial is testing

Efficacy and Safety of TT-00420 (Tinengotinib) Tablets Versus Chemotherapy in Patients With Advanced Intrahepatic Cholangiocarcinoma Harboring FGFR2 Fusions/Rearrangements or Mutations

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)Advanced Cholangiocarcinoma
TransThera Sciences (Nanjing), Inc. 138
Early research (Phase 1)Not Yet RecruitingNCT06490198
What this trial is testing

Phase 2 Study: OBI-833/OBI-821 Maintenance for Globo H+ Advanced Biliary Tract Cancer After Gemcitabine/Cisplatin

Who this might be right for
CholangiocarcinomaChemotherapy EffectImmunotherapy
Chang Gung Memorial Hospital 30
Not applicableStudy completedNCT02551263
What this trial is testing

Eribulin Treatment as 1st-line or 2nd-line Chemotherapy for HER2-negative Hormone-resistant Inoperable or Recurrent Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan 201
Next Page